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Replica exchangePhosphorylation of phospholamban (PLB) at Ser16 and/ or Thr17 is believed to release its inhibitory effect on
sarcoplasmic reticulum calcium ATPase. Ser16 phosphorylation of PLB has been suggested to cause a confor-
mational change that alters the interaction between the enzyme and protein. Using computer simulations,
the conformational sampling of Ser16 phosphorylated PLB in implicit membrane environment is compared
here with the unphosphorylated PLB system to investigate these conformational changes. The results suggest
that conformational changes in the cytoplasmic domain of PLB upon phosphorylation at Ser16 increase the
likelihood of unfavorable interactions with SERCA in the E2 state prompting a conformational switch of
SERCA from E2 to E1. Phosphorylation of PLB at Thr17 on the other hand does not appear to affect interac-
tions with SERCA signiﬁcantly suggesting that the mechanism of releasing the inhibitory effect is different be-
tween Thr17 phosphorylated and Ser16 phosphorylated PLB.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Phospholamban (PLB), a 52 residue transmembrane (TM) protein,
plays an essential role in regulating sarco-/endoplasmic reticulum calci-
um ATPase (SERCA), a calcium pump in heart muscle [1] by reducing
the enzyme afﬁnity for calcium [2]. PLB can be phosphorylated at
Ser16 and/or Thr17 by cAMP-dependent protein kinase A (PKA) and
Ca2+-calmodulin dependent protein kinase (CAM kinase), respectively,
in response to β-adrenergic stimulation [3]. PLB phosphorylation in-
creases the Ca2+ afﬁnity of SERCA and releases the inhibitory effect
[4]. Several in vivo studies have shown that phosphorylation of Ser16
and Thr17 is sequential [5,6]. In vitro studies in sarcoplasmic reticulum
(SR)membranes on the other hand have shown that Thr17 phosphory-
lation can be stimulated by electrical pulse without the prerequisite of
Ser16 phosphorylation [7–9]. It has been suggested that the sequential
phosphorylation in vivo is a result of interactions between PKA and
CaMKII pathways [10]. Ser16 phosphorylation of PLB appears to be suf-
ﬁcient to release the inhibitory effect for themaximumcardiac response
to β-adrenergic stimulation [11]. Therefore, the physiological role of
Thr17phosphorylation is not fully understood yet. Interestingly, aerobic
interval training preferentially increases Thr17 phosphorylation [12]. It
has been suggested that Thr17 and Ser16 phosphorylationmay have antry and Molecular Biology,
. Tel.: +1 517 432 7439.
rights reserved.additive effect in releasing the inhibitory function of PLB both in vitro
[13,14] and in vivo [15]. The possibly different physiological role of
Ser16 vs. Thr17 phosphorylation may also point at mechanistic differ-
ences in SERCA–PLB interactions with PLB phosphorylation at either
site.
To better understand the mechanism by which Ser16 and/or
Thr17 phosphorylation relieves inhibition of SERCA by PLB, detailed
knowledge of the structural changes of PLB upon phosphorylation is
essential. Most experimental and computational studies have been
focused on unphosphorylated PLB and relatively little detailed struc-
tural information is available for phosphorylated PLB. NMR studies
of unphosphorylated PLB in DPC micelles [16] and lipid membranes
[17,18] suggest an ensemble of L-shaped structures where a long
TMhelix is connected to a dynamic cytoplasmic (CP) helix via a ﬂexible
linker. Based on NMR data, average interhelical angle of 80±20° has
been reported in different solutions [19], micellar and membrane envi-
ronments [16,18], while other experimental data indicate that the CP
domain of PLB is in fact in equilibrium between dynamically ordered
and disordered conformations [20,21]. The average structural proper-
ties and conformational dynamics of PLB have been reproduced by mo-
lecular dynamics (MD) simulations from our group [22] and others
[23–27].
Phosphorylation of PLB appears to shift the equilibrium of the cy-
toplasmic helix towards a “disordered” state [28,29], although the
exact molecular interpretation of this ﬁnding is unclear. Furthermore,
a reduction of helical content in the CP helix upon Ser16 phosphory-
lation has been suggested from CD [30], NMR [31] and attenuated
total reﬂection FTIR (ATR-FTIR) experiments [32]. NMR studies on a
Fig. 1. Reaction coordinates used in generating the PMF plots; interhelical angle, θ, and
the distance between the center of mass of the CP helix from its projection onto the TM
helical axis, d-COM. Shorter CP helical domain that is used to deﬁne θ is colored differ-
ently as well as the TM domain.
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lated PLB also report a shorter CP helix from residues 2 to 12 [33],
while the interhelical angle in double phosphorylated PLB appears
to be increased to 100±35° [33]. Results from ﬂuorescence reso-
nance energy transfer (FRET) studies indicate a reduced interdomain
distance between residues Tyr6 and Cys24 after Ser16 phosphoryla-
tion [34]. This is consistent with ﬂuorescence quenching studies of
Tyr6, suggesting that phosphorylation reduces the solvent accessibil-
ity of Tyr6 as a result of a conformational change [35].
Several experimental studies are consistent with the idea that PLB is
still attached to SERCA after phosphorylation [29,34,36–39]. On the
other hand, an earlier cross-link study reported the abolishment of
cross-links between SERCA and PLB upon phosphorylation by PKA [40],
whichwas interpreted as complete dissociation of PLB from SERCA. How-
ever, a more recent cross-link study is more consistent with the data
supporting the hypothesis that PLB does not dissociate from SERCA
upon phosphorylation [41]. In that study, phosphorylation of PLB on
Ser16 increased the distances between certain residues of PLB and
SERCA while other cross-links remained the same [41]. An early EPR
study also suggests the complete dissociation of PLB from SERCA [42].
There, the shift to the pentameric state of PLB upon phosphorylation
was observed in the pentamer–monomer PLB equilibrium. This shift
was interpreted as an evidence for dissociation of PLB from SERCA,
which binds to the monomeric state of PLB [42]. Finally, ﬂuorescence
measurements of PLB–SERCA co-crystals have suggested an alternative
hypothesis that phosphorylation of PLB may relieve the inhibitory effect
by facilitating the structural coupling between two interacting SERCA
units that is otherwise disrupted by unphosphorylated PLB [43].
A few MD simulations of phosphorylated PLB (pPLB) have been
reported to date and resulted in the following ﬁndings. A decrease
in helicity was observed upon Ser16 phosphorylation in simulations
of the cytoplasmic PLB domain (residues 1–25) [24]. MD simulations
of full length pPLB in an explicit POPC membrane bilayer also showed
a decrease in the helical content while interactions of phosphoserine
with the membrane head group region appeared to result in lower
mobility of the CP domain [27]. Another MD simulation study using
both replica exchange simulations of the CP domain of PLB and a con-
stant temperature MD simulation of full-length pPLB has provided
further insights. The results from this study suggest a decrease in
the interdomain distance, a decreased interhelical angle, and again a
loss of helical contents in the CP helix upon phosphorylation as a re-
sult of interactions between the Ser16 phosphate group and residues
Arg9, Arg13 and/or Arg14 [25]. These simulations of pPLB provide im-
portant insight into the structure and dynamics of PLB upon phos-
phorylation but the covered time scales remain relatively short
compared to the experimentally observed dynamics, reaching at
best tens of nanoseconds in the replica exchange runs.
In order to describe the dynamics of phosphorylated PLB over
much longer time scales, we are reporting here results from replica
exchange implicit membrane simulations of PLB that is phosphorylat-
ed either at Ser16 or at Thr17. We used here the HDGB implicit
membrane model that has been successfully applied in previous sim-
ulations of unphosphorylated PLB [22], inﬂuenza fusion peptide [44],
and integral membrane proteins [45]. An implicit description of the
membrane and solvent drastically accelerates sampling because
lipid relaxation processes are avoided. We estimate that the combina-
tion of using the implicit membrane model with replica exchange
sampling provides access to dynamics that would otherwise be ob-
served on microsecond to millisecond time scales. The drawback of
using an implicit approach is of course the neglect of explicit
lipid-peptide interactions; however, previous studies from our
group suggest that the HDGB model used here is able to capture the
structure and dynamics of membrane-bound peptides, including
PLB, in a highly realistic fashion [22,44].
In the following, the methods used here are brieﬂy summarized
before the results are presented and discussed.2. Methods
2.1. Simulations
Replica exchange MD simulations [46] of monomeric PLB phosphory-
lated at Ser16 (p16-PLB) or Thr17 (p17-PLB) were carried out and com-
pared with a previous simulation of unphosphorylated PLB [22]. Model
1 of the NMR ensemble for the C36A/C41F/C46A PLB mutant (PDB ID:
1N7L [16])was used as the initial structure. Zwitterionic termini and stan-
dard protonation states (pH=7) were applied. The phosphoserine and
phosphothreonine side chains were assumed to be fully deprotonated
with a −2 charge. Starting conformations were oriented in the implicit
membranewith the transmembrane (TM)helix parallel to themembrane
normal and the cytoplasmic (CP) helix above and parallel to the mem-
brane surface. The CHARMM22 all-atom force-ﬁeld [47] along with the
CMAP correction term [48] was used to describe the peptide interactions.
No cutoffs were applied to the non-bonded interactions. The implicit
description of the membrane involved the heterogeneous dielectric
generalized Bornmodel (HDGB) [49]. Optimized parameters for DPPC bi-
layer [22] were used in all simulations. Other implicit solvent parameters
were set as described previously [50]. The SHAKE algorithm [51] was
applied to constrain bonds involving hydrogen atoms. To control the tem-
perature, Langevin dynamics [52] was used with a friction coefﬁcient of
10 ps−1 applied to heavy atoms [53]. A time step of 1.5 fs was used to
maintain stable simulations with the implicit membrane model as de-
scribed previously [54]. All simulations were carried out with version
34a2 of CHARMM [55] in combination with the MMTSB Tool Set [56].
Replica exchange simulations consisted of eight replicas over a
temperature range of 300–400 K, spaced exponentially. All of the rep-
licas were started with energy-minimized structures. Exchanges were
attempted after every 500MD steps (0.75 ps). The resulting exchange
acceptance ratio was 21–30% between adjacent replicas. Four separate
replica exchange simulations were carried out for each system and
sampling data were combined to improve statistical signiﬁcance [22].
Each simulation was carried out for 50,000 cycles (37.5 ns/replica)
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not included in the analysis. The total length of the production runs is
67.5 ns (22.5 ns for each simulation) for the non-phosphorylated PLB
and 90 ns for the p16 and p17 phosphorylated PLB systems (22.5 ns
for each simulation).
The weighted histogram analysis method (WHAM) [57] was used
to generate potentials of mean force (PMFs) at 300 K to include sam-
pling data at higher temperatures as well. The interhelical angle and
the distance between the center of mass of the CP helix and its projec-
tion onto the TM helix (d-COM) were chosen as the primary reaction
coordinates for generating the PMFs (see Fig. 1). The interhelical
angle (θ) is deﬁned as the angle between the CP (residues 4–12)
and TM (residues 23–52) helical axis. The center of mass of the CP
helix was calculated based on residues 1 to 16. Note that the deﬁni-
tions of the reaction coordinates here are slightly different from our
previous deﬁnition [22] to better describe conformations with less
well-deﬁned helical structure. Further analysis involved clustering
with the K-means method as implemented in the MMTSB Tool Set
[56]. PyMOL was used to generate molecular graphics [58]. MATLABFig. 2. PMFs as a function of θ and d-COM (see Fig. 1), for (A) PLB, (B) p16-PLB, (C) p17-PLB
Mapping structures with (shown with ) and without clash (shown with ) in the θ and d-C
sterically incompatible with complex formation are shown in the middle column in black,version 7.9.0.529 (R2009b) was used to generate PMFs and for data
mining analysis.
2.2. SERCA–PLB docking
In order to test whether different PLB conformations are likely to
interact favorably with SERCA the following procedure was applied.
The TM domain of PLB composed of residues 21–52 (called T-PLB)
from the NMR structure (PDB ID: 1N7L) was manually docked to
the structure of SERCA in the E2 conformation (PDB ID: 1IWO [59]).
To obtain the docked complex, cross-linking information according
to Table S1 was used [60-63]. The ﬁnal distances in the resulting
SERCA–PLB complex were close to the cross-linking distances (see
Table S1). TM domain of all different conformations of PLB and phos-
phorylated PLB were then aligned to the docked T-PLB. From all of the
aligned PLB structures, residues 1–22 (called cpPLB) were selected
and added to the PDB structure of SERCA in the E2 conformation.
The complexes were minimized for only 100 steps to correct any pos-
sible clashes between the side chains of the two proteins. In order to. Representative structures from cluster analysis that correspond to minima are shown.
OM coordination space for (D, G) PLB, (E, H) p16-PLB, and (F, I) p17-PLB. Conformations
compatible conformations are shown in red in the right column.
Fig. 3. Representative structures from cluster analysis for (A1-7) PLB, (B1-7) p16-PLB, and (C1-7) p17-PLB that correspond to minima on Fig. 2A–C. In all structures, the orientation
with respect to the membrane was preserved. Lines represent the membrane hydrophobic core and are placed at 15 Å distance above and below the membrane center (z=0).
Ser16 in B1-7 and Thr17 in C1-7 are shown with stick representation. Cluster population percentages are given in parentheses.
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then reduced to a coarse-grained (CG) model with a single site per
residue. The CG model was used to focus on the overall shape com-
patibility and avoid excessive sensitivity to individual atomic contacts
that could be relieved through side chain reorientation. The TMFig. 4. Average helicity distribution for different residues for PLB ( ), p16-PLB ( )
and p17-PLB ( ).domain of PLB in all of the structures is well-preserved in the simula-
tions. Therefore, only the CP domain of PLB is included in the com-
plexes and calculation of the docking score. Each CG particle is
placed at the average position of all the atoms in a given residue.Fig. 5. Distribution of the interdomain distance between the oxygen atom of the hy-
droxyl group on Tyr6 and the Cβ atom of Ala24 for PLB ( ), p16-PLB ( ), and
p17-PLB ( ).
Table 1
Comparison between the calculated properties from the simulation and experimental values for the PLB and phosphorylated PLB systems. Uncertainties are obtained from compar-
ing values between different simulations. Standard deviations are given in parentheses.
Simulation Experiment
PLB p16‐PLB p17-PLB PLB p16-PLB
Interhelical angle (°)a 77.4±7.1
(26.8)
98.0±8.2
(31.0)
89.7±6.2
(36.4)
~80±20 [16-19]
~66 [18]
N/A
Interdomain distance (Ǻ)b 17.3±1.0
(4.4)
15.3±2.6
(7.1)
17.9±1.2
(7.5)
21.1±0.9 [34] 18.2±.0.6 [34]
Solvent exposed area of Tyr6 (Ǻb) 139.9±2.3
(21.6)
66.4±30.1
(54.2)
129.5±4.6
(35.6)
31% Decrease
upon phosphorylation [35]
a Angle between the CP and TM helical vectors.
b Distance between Ala24 Cβ and the Tyr6 hydroxyl oxygen.
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score with the parameters reported in Table S2. Energies were then
calculated for the CG models of the SERCA–cpPLB complexes to deter-
mine whether CP domain of PLB structures clash with SERCA or not.
An energy cutoff of 20 kcal/mol was found to roughly match a more
subjective analysis based on visual inspection. Following this proto-
col, the structural ensembles from the simulations were evaluated
to determine the fraction of conformations that are likely to interact
favorably with SERCA.
3. Results
Replica exchange simulations of phosphorylated PLB are com-
pared here with previous simulations of unphosphorylated PLB [13].
In order to characterize the dynamics of the cytoplasmic (CP) helix,
the simulation data were ﬁrst analyzed in terms of the angle between
the TM and CP helices, θ, and the distance of the center of mass of the
CP helix from its projection on the TM helical axis, d-COM (see
Methods section for detailed deﬁnitions). The resulting PMFs and rep-
resentative structures corresponding to the minima are shown in
Figs. 2A–C and 3, respectively. A wide range of structures was sam-
pled with either of the two phosphorylation states. Generally, the en-
sembles include compact structures, where the CP helix interacts
with the membrane interface, and extended structures, where the
CP helix points away from the membrane. Compact structures include
L- and T-shaped states with θ values between 50 and 90° as well as
conformations with small values of θ of less than 30°, where the CP
helix is packed in an antiparallel fashion against the TM helix.
In unphosphorylated PLB, most of the sampling involves L- and
T-shaped structures with a small additional population of extended
states (see Figs. 2A and 3). Upon phosphorylation at Ser16, additional
local minima regions appear in the free energy landscapes. The mostFig. 6. Distribution of Tyr6 solvent accessible surface area for PLB ( ), p16-PLB ( ),
and p17-PLB ( ).dominant structures are still L- and T-shaped states (cf. B3, B4, and B5
in Fig. 3) with the L-shaped structures more populated relative to the
unphosphorylated state. Looking at Fig. 3 it can be seen that structures
in themost populated cluster B5 as well as in B6 have a break in the CP
domain. These structures are not observed in unphosphorylated PLB
and are apparently stabilized by extra hydrogen bonds that involve
the phosphorylated Ser16. On the other hand, structures with small
θ values below 30° are less populated and structures with θb10° are
absent altogether in the Ser16 phosphorylated PLB ensemble. This
can also be explained by extra hydrogen bonds formed in the CP do-
main. These extra hydrogen bonds cause the CP helix to break and
the N-terminal part comes upward and points away from the mem-
brane center instead if inserting deeply into the membrane. Reduced
helicity in the CP helix upon Ser16 phosphorylation is also apparent
in the other structures shown in Fig. 3 (cf. B3 and B7). Thr17 phos-
phorylation, on the other hand, leads to an ensemble that is more sim-
ilar to unphosphorylated PLB. However, there is more signiﬁcant
sampling of extended structures (θ>150°) as well as structures with
small values of θ (θb30°). T-shaped conformations with small
d-COM values (like B4) appear to be less prominent upon Thr17 phos-
phorylation (see Fig. 2), while highly extended conformations and
completely L-shaped conformations such as C1 and C4 in Fig. 3 are
sampled more extensively.
To understand the effect of phosphorylation further, a number of
other structural properties were analyzed. First, the average helicity
was calculated as a function of residue number. The results, presented
in Fig. 4, show that phosphorylation at Ser16 signiﬁcantly reduces the
helicity in the CP domain of PLB. This is in agreement with the experi-
mental data [31,32] and conﬁrms results from previous simulation
studies [24,27,46]. NMR studies of the PLB (1–25) peptide suggest that
residues 12 through 17 unwind upon phosphorylation at Ser16 [30].
According to NMR studies of the full-length monomeric PLB, residues
14 through 17 from the C terminus and residue 3 from the N terminus
of the CP helix in the Ia domain of PLB unfold upon phosphorylation
at Ser16 [28]. As it is shown in Fig. 4, on average, residues 7 through
11 from the CP helix lose their high helical content upon phosphoryla-
tion at Ser16. The number of residues that lose their helical property
is more than what is suggested by NMR study of the full-length PLB
[28] but is in good agreement with the NMR study of the PLB (1–25)
peptide [30]. The helical content of the Ib domain is not inﬂuenced by
the Ser16 phosphorylation of PLB in agreement with the NMR data
[28]. Interestingly, phosphorylation at Thr17 does not appear to affect
helicity compared to the unphosphorylated PLB.
Second, interdomain distances between the oxygen atom of the
hydroxyl group on Tyr6 and the Cβ atom of Ala24 were calculatedTable 2
Predicted percentage of PLB structures that clash with SERCA in the E2 state as a func-
tion of phosphorylation.
Phosphorylation None Ser16 Thr17
Percentage of structures that clash with SERCA 38 69 48
Fig. 7.Manually dockedmodel of PLB and p16-PLB into SERCA in the E2 conformation. PLB
and p16-PLB structures correspond to the minima in the PMFs and SERCA structure is
from the crystal structure with the PDB entry code of 1IWO. Upper part of the TM helix
numberM9of SERCA and a part of the loop connecting helicesM8 andM9are highlighted.
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ly as a function of the phosphorylation state. In its unphosphorylated
state, PLB exhibits interdomain distances that lie mostly between 12
and 22 Å. Upon phosphorylation, a diverse set of structures gives rise
to a much broader distribution with distances between 3 and 30 Å.
Phosphorylation at Thr17 results in a slightly wider interdomain dis-
tances relative to Ser16 phosphorylated conformations. FRET experi-
ments have suggested that phosphorylation of PLB at Ser16 decreases
the interdomain distance by 3 Å [34]. From the simulations, we found
a 2 Å decrease in the overall average interdomain distance, which is con-
sidered to be in excellent agreementwith experimental data (see Table 1)
considering the uncertainties in interpreting the FRET data when sam-
pling of multiple conformations with a wide distribution of distances is
involved.
The solvent accessibility of Tyr6 was further analyzed by calculating
its solvent accessible surface area (SASA). We found that phosphoryla-
tion at Ser16 increases sampling of conformationswhere Tyr6 is partial-
ly or completely buried. In unphosphorylated PLB, Tyr6 is solvent-
exposed in almost all of the structures (see Fig. 6). The average
solvent-accessible surface area (see Table 1) is reduced by 52% upon
Ser16 phosphorylation, but the margin of error is relatively large. This
result agrees at least qualitatively with the 31% decrease in the
solvent-accessibility measured by ﬂuorescence studies [35].
Finally, the key question is how the conformational changes in PLB
upon phosphorylation affect interactions with SERCA and how Ca2+
ﬂux is consequently regulated by PLB. While full experimental struc-
tures of SERCA–PLB complexes are not available so far, EPR data suggest
that by binding to SERCA, the equilibrium between the R and T states of
PLB shifts toward the R state without introducing new conformational
states for PLB [38]. Under the assumption that PLB in the PLB–SERCA
complex resembles conformations seen also in the monomeric form,
we performed docking of the PLB structures sampled in our simulations
(in the absence of SERCA) to the inactive E2 conformation of SERCA.
This was achieved by docking the TM helix of PLB into SERCA according
to the cross-linking data ﬁrst and then, superimposing each of the sam-
pled PLB structures at the TM helix region (see Methods section for
more details). We then analyzed the clashes between the CP helix of
PLB and SERCA to determine whether the complex was viable. The re-
sults of this analysis are given in Table 2. It is found that about 60% of
the conformations of unphosphorylated PLB but only 31% of the confor-
mations of Ser16-phosphorylated sampled in the absence of SERCA are
structurally compatible with complex formation. We note, that the
quality of the intermolecular interactions plays an additional role in de-
termining SERCA–PLB interactions. However, without reliable structur-
al information, such an analysis is likely not meaningful and was
therefore not carried out here. Based on the differences in the amount
of steric clashes, the simulation results predict that Ser16 phosphoryla-
tion would have a destabilizing effect on the PLB–SERCA–E2 complex
and likely require a conformational rearrangement of PLB with respect
to SERCA if Ser16 phosphorylated PLB stays bound to SERCA as
suggested by experiments [29,34,36–38]. Presumably, such a change
would allow SERCA to switch from E2 to the active E1 form. Interesting-
ly, Thr17 phosphorylation seems to have a different effect. About half
of the conformations sampled in the simulation are still compatible
with complex formation. Therefore, at least the interaction of the
PLB's CP helix with SERCA may not be completely different from the
unphosphorylated complex.
To understand the conformational characteristics of the structures
that clash with SERCA better, the sampled conformations were divided
into two groups based on whether they clash with SERCA or not. In
Fig. 2D–I all these structures have been projected onto θ and d-COM for
the PLB and phosphorylated PLB ensembles. Comparing Fig. 2E, F, H,
and I shows that even thoughmost of the L- and T-shaped conformation
with θ values between 60 and 100° potentially clash with SERCA in the
Ser16 phosphorylated state, L- and T- shaped Thr17 phosphorylated
PLB structures are compatiblewith SERCA. This suggests that the sampledL- and T-shaped structures, which are the most sampled conformations
in phosphorylated states, are structurally different in Ser16 and Thr17
phosphorylated PLB.
4. Discussion
In this paper, the effects of Ser16 and Thr17 phosphorylation on
the conformational sampling of PLB were studied and compared
with a previous study of PLB in DPPC bilayer by means of the HDGB
implicit membrane model [22]. To the best of our knowledge, this
work is the ﬁrst simulation reported for single site phosphorylated
PLB at Thr17. This work also covers the conformational sampling of
p16-PLB over time scales that are much longer than previously
reported simulations of p16-PLB. Previous short explicit simulations
did not reach the time scales needed for lipid relaxation or focused
only on the CP domain of PLB in water. Using an implicit description
of the membrane with the HDGB model allowed us to cover much
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more, the use of replica exchange simulation methodology and aver-
aging over multiple separate simulations further increased the
effective time scales much beyond of what could be reached with
conventional constant-temperature explicit lipid simulations. We es-
timate that although our simulations are only on the scale of tens of
nanoseconds, the dynamics described here occurs in reality on micro-
second to millisecond timescales as a result of the combined acceler-
ation from replica exchange sampling and avoidance of slow lipid
relaxation kinetics.
The key ﬁnding of the presentwork is that phosphorylation of PLB at
Ser16 signiﬁcantly affects conformational sampling of PLB in the CP do-
main in such away that it increases the chances of a clashwith SERCA in
the E2 state. Upon phosphorylation at Ser16, the helical content of the C
terminus of the CP domain reduces and new conformations with a
break in the CP domain are sampled. Also structures with completely
buried Tyr6 residue are observed for p16-PLB. These types of conforma-
tions are not observed for p17-PLB. Our results suggest that if p16-PLB
remains in the same binding site as PLB, the number of clashes between
SERCA and PLB increases signiﬁcantly. To remain bound to SERCA, we
therefore hypothesize that p16-PLB changes its interaction site to pre-
vent such clashes. A model constructed from crystal structure of
SERCA in the E2 form and one of the most sampled p16-PLB structures
in our simulation is shown in Fig. 7. This complex model takes into ac-
count available cross-link data for p16-PLB, which is summarized in
Table S1 (see Methods section). For comparison, a model constructed
with one of the most highly populated structures in our previous
simulation of unphosphorylated PLB simulation [22] and SERCA–E2
complex is shown in Fig. 7. The use of the cross-link data introduces un-
certainty into the proposed complex model, but while individual
cross-links provide only loose restraints, combined data from all avail-
able cross-links limit the possibility for alternative conformations. As
can be seen, the TM domain of p16-PLB is more detached from SERCAFig. 8. A hypothetical diagram for the interaction of PLB and SERCA. Phosphorylation of PLB a
to SERCA. The p17PLB hypothetically detaches from SERCA. Either phosphorylation pathwarelative to the TM domain of PLB in order to prevent clashes between
themembrane-inserted CP domain of p16-PLB and the loop connecting
helices M8 and M9 in SERCA (highlighted in Fig. 7). Such a partial
detachment is consistent with the cross-links reported for the lower
part of helix M4 in SERCA after PLB phosphorylation at Ser16 [41]. Pre-
vious modeling studies of the PLB–SERCA complex have suggested that
the TMdomain of PLB closely interactswith a groove constructed by he-
lices M2, M4, M6 and M9 of SERCA in the E2 state in the absence of cal-
cium ions thereby preventing SERCA fromundergoing a conformational
switch to E1 [40]. According to ourmodel, p16-PLB becomes sufﬁciently
detached from this groove to allow the transition fromE2 to E1 and sub-
sequently enable enzyme activity [29,34].
The case of p17-PLB appears to involve a different mechanism.
According to our results, the conformations sampled for p17-PLB
are still largely compatible with the tight complex proposed for
unphosphorylated PLB. A possible explanation for how p17-PLB
may nevertheless regulate SERCA activity would involve a shift in
binding equilibrium towards PLB dissociation upon p17 phosphory-
lation. The two different proposed mechanisms for Ser16 and Thr17
phosphorylation are illustrated in Fig. 8. We further speculate that
Ser16 phosphorylation may be the typical regulatory mechanism
for normal cycling of SERCA activity while Thr17 phosphorylation
may become involved under special circumstances where complete
PLB dissociation is more desirable.
Ser16 phosphorylation alone is sufﬁcient for the maximal cardiac
response to β-adrenergic stimulation [11]. However, differential ef-
fects have been reported for Thr17 phosphorylation with respect to
the frequency dependence during electrical stimulation [8,9], in in-
creased heart cell contractions, in calcium transients of aerobic inter-
val trained mice [12], and during mechanical recovery after stresses
like acidosis and stunning [15]. Based on these observations, Thr17
phosphorylation of PLB may play a role when fast changes in the
heart rate are needed or when a fast response is required for heartt Ser16 changes the binding site of SERCA and p16-PLB while PLB is still partially bound
y induces the E2 to E1 conformational change in SERCA and activates the pump.
584 M. Sayadi, M. Feig / Biochimica et Biophysica Acta 1828 (2013) 577–585functioning such as an electric shock. Complete dissociation of PLB as
proposed for p17-PLB may facilitate a more rapid activation of SERCA
compared to p16-PLB, which is proposed to remain bound to SERCA.
Clearly, further studies are needed to understand these questions
more completely. In particular, there is a need for more detailed
structural data with respect to PLB–SERCA interactions.
Several in vivo studies suggest a sequential nature of phosphorylation
[5,64,65] on the two phosphorylation sites and indicate that Thr17 phos-
phorylation may typically depend on PLB pre-phosphorylation at Ser16
[66]. Furthermore, experimental studies have suggested an additive effect
of double-phosphorylation in terms of activating SERCA [13-15]. This
raises the questions of how the double-phosphorylation state affects the
conformational sampling of PLB compared to the single-phosphorylated
PLB variants. Simulations of the double-phosphorylated state are difﬁcult
because of signiﬁcant pKa shifts expected to result from two neighboring
phosphate groups that are likely to partial charge neutralization of one of
the phosphates. Because we expect that the pKa shifts are strongly
coupled to conformational changes of PLB, we believe that pH dynamics
simulation techniques are needed to adequately study this system. Such
simulations are outside the scope of this study but are being considered
in future work.
5. Conclusion
Conformational changes introduced by phosphorylation of PLB at
Ser16 and Thr17 have been studied throughmolecular dynamics simula-
tions. Taking advantage of an implicit membrane environment and repli-
ca exchange sampling phosphorylated PLB conformations were sampled
on estimated microsecond–millisecond timescales. Phosphorylation on
either site introduced different changes in the conformational sampling
and the resulting energy landscapes. Phosphorylation at Ser16 increases
the chances of clash with SERCA and suggests that steric effects cause
the reorientation of PLB respect to SERCA. Thr17 phosphorylation, on
the other hand, does not seem to increase the number of clashed struc-
tureswith SERCA signiﬁcantly. This suggests that instead of reorientation,
PLBmay dissociate from SERCA after phosphorylation on Thr17. Based on
the model we present here Ser16 and Thr17 phosphorylation of PLB ap-
pear to have different mechanisms, which may reﬂect different physio-
logical role of each individual phosphorylation.
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